<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="177">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621539</url>
  </required_header>
  <id_info>
    <org_study_id>58259</org_study_id>
    <nct_id>NCT04621539</nct_id>
  </id_info>
  <brief_title>Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients</brief_title>
  <acronym>COLOSSAL</acronym>
  <official_title>Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) Predictive Model in the Prediction of Severe Infection - Sepsis in Obstetric Patients and Adverse Neonatal Outcomes: a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research problem: In 1991, the terms Systemic Inflammatory Response Syndrome (SIRS), severe&#xD;
      sepsis, and septic shock were introduced, based on the pro-inflammatory theory, conforming to&#xD;
      a list of classification criteria for each one. New criteria were recently created in search&#xD;
      of coherence with the pathophysiological process that generates the infection in the host:&#xD;
      SOFA and qSOFA scores. Neither of these two criteria has been standardized in the obstetric&#xD;
      patient, taking into account the physiological alteration of many of the clinical and&#xD;
      laboratory parameters that occur in pregnancy. The question that arises then is: Are the new&#xD;
      sepsis criteria qSOFA and SOFA valid in comparison with the previous SIRS criteria for&#xD;
      predicting adverse maternal and neonatal outcomes in obstetric patients diagnosed with&#xD;
      infection? Aim: To evaluate the predictive model quick Sequential [Sepsis-related] Organ&#xD;
      Failure Assessment (qSOFA) in comparison with the SIRS criteria for the prognosis of severe&#xD;
      infection-sepsis in obstetric patients and adverse neonatal outcomes in different cities of&#xD;
      Colombia.&#xD;
&#xD;
      Methodology: a longitudinal prospective cohort multicenter study will be carried out in&#xD;
      selected centers in Colombia, with a data collection duration of at least 12 months. Data&#xD;
      will be collected on clinical characteristics, health outcomes, and medical practices. Study&#xD;
      participants will be followed during their stay at the health center. Follow-up will end at&#xD;
      hospital discharge, transfer to a facility outside of participating geographic areas, or&#xD;
      death. Neonates born to mothers included in the study will be followed until discharge from&#xD;
      the hospital or 7 days after birth if they are still in the hospital, whichever comes first.&#xD;
&#xD;
      Expected results: This study seeks to evaluate the predictive model q SOFA and the prognosis&#xD;
      of sepsis in obstetrics in comparison with the SIRS criteria, hoping to find that qSOFA is&#xD;
      superior to the SIRS criteria for the identification of which obstetric patients diagnosed&#xD;
      with an infection they will progress to sepsis and which patients with sepsis progress to&#xD;
      septic shock, this would translate both at the maternal and neonatal level in a reduction of&#xD;
      adverse events, prolonged stays, disabilities, sequelae, in addition to allowing preventive&#xD;
      actions and control, which finally translate into protocols that allow better management of&#xD;
      this entity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">November 13, 2019</completion_date>
  <primary_completion_date type="Actual">November 13, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Admission to intensive care unit</measure>
    <time_frame>28 days</time_frame>
    <description>need or admission to an intensive care unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Use of vasopressors</measure>
    <time_frame>28 days</time_frame>
    <description>use of vasoactive drugs (norepinephrine, epinephrine, vasopressin)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prolonged ICU stay</measure>
    <time_frame>28 days</time_frame>
    <description>Stay in intensive care unit for 72 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional interventions</measure>
    <time_frame>28 days</time_frame>
    <description>need for surgery (cesarean section - emergency hysterectomy, hysterectomy, chest tubes, etc.), invasive mechanical ventilation, use of arterial line, among others.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2125</enrollment>
  <condition>Severe Infection</condition>
  <arm_group>
    <arm_group_label>Infected without an SMO</arm_group_label>
    <description>Defined as an acute infection not associated with admission to the intensive care unit (ICU), mechanical ventilation, or the use of vasopressors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infected with an SMO</arm_group_label>
    <description>defined as an acute infection associated with intensive care unit (ICU) admission, mechanical ventilation, or vasopressor use.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women, childbirth or within 42 days of termination of pregnancy, with infectious&#xD;
        symptoms of any kind (obstetric - non-obstetric) who attend and are hospitalized in the&#xD;
        selected clinics during the study period.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in a state of pregnancy with a single fetus between 14 and 49 years old.&#xD;
&#xD;
          -  Pregnant women (any gestational age) defined as a positive gravindex test and an&#xD;
             obstetric ultrasound to prove it.&#xD;
&#xD;
          -  Any suspected or confirmed infection during current hospital stay (primary admission&#xD;
             or readmission) with or without organ dysfunction&#xD;
&#xD;
          -  Any clinical signs suggestive of infection (eg, fever)&#xD;
&#xD;
          -  Request for culture of body fluids (blood, urine, cerebrospinal fluid, etc.) or swab&#xD;
             specimen (nasopharyngeal, oropharyngeal);&#xD;
&#xD;
          -  Non-prophylactic use of antibiotics or other antimicrobials during admission or during&#xD;
             hospital stay.&#xD;
&#xD;
          -  Any health care related infection (eg, surgical site, episiotomy, IV, venipuncture,&#xD;
             urinary catheterization, central line, etc.)&#xD;
&#xD;
          -  Urinary tract infection of the lower urinary tract that requires hospitalization and&#xD;
             in-hospital management for more than 48 hours.&#xD;
&#xD;
          -  Herpes simplex, herpes zoster (shingles) with associated liver failure.&#xD;
&#xD;
        Note: observations on the inclusion criteria:&#xD;
&#xD;
          -  Eligible women who remain in the health center for 12 hours or more, regardless of&#xD;
             formal administrative admission, will be included in the study.&#xD;
&#xD;
          -  Eligible women admitted or readmitted to a participating health center, regardless of&#xD;
             length of hospital stay, will be included in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women of any age who do not sign the informed consent.&#xD;
&#xD;
          -  Pregnant minors who do not sign the consent.&#xD;
&#xD;
          -  Any non-serious or localized infection&#xD;
&#xD;
               -  Vaginosis, candidiasis&#xD;
&#xD;
               -  Fungal skin infections (athlete's foot, ringworm)&#xD;
&#xD;
               -  Otitis o Pharyngitis&#xD;
&#xD;
          -  Any chronic uncomplicated infection&#xD;
&#xD;
               -  Sexually transmitted infections (gonorrhea, syphilis, Trichomonas, chlamydia,&#xD;
                  hepatitis, HIV).&#xD;
&#xD;
               -  Tuberculosis.&#xD;
&#xD;
          -  Any colonization Microorganisms without clinical signs / symptoms)&#xD;
&#xD;
               -  Known vaginal, urethral and / or rectal colonization of group B beta-hemolytic&#xD;
                  streptococcus.&#xD;
&#xD;
               -  Asymptomatic bacteriuria&#xD;
&#xD;
               -  Known oropharyngeal colonization&#xD;
&#xD;
          -  Patients with surgical wound infection other than caesarean section (hysterectomy,&#xD;
             laparotomy or others)&#xD;
&#xD;
          -  Any iatrogenic / hyperthermic hypothermia (eg related to epidural, thyroid storm,&#xD;
             prostaglandin administration) during hospital stay.&#xD;
&#xD;
          -  Use of any prescription of prophylactic antibiotics (eg, for colonization of&#xD;
             beta-hemolytic streptococcus group B, after cesarean section, manual removal of the&#xD;
             placenta, vaginal delivery);&#xD;
&#xD;
          -  Patients referred from other institutions with more than 24 hours of management&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Carmelo R Dueñas-Castell, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gestion Salud IPS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gestion Salud</name>
      <address>
        <city>Cartagena</city>
        <state>Bolivar</state>
        <zip>130015</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <link>
    <url>https://www.who.int/news-room/fact-sheets/detail/maternal-mortality</url>
    <description>Maternal mortality - WHO</description>
  </link>
  <link>
    <url>https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2017%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2021.pdf</url>
    <description>Weekly Epidemiological Bulletin, number 21 of 2017 (May 21 - May 27)</description>
  </link>
  <link>
    <url>https://www.ins.gov.co/Direcciones/ONS/Resumenes%20Ejecutivos/Resumen%20ejecutivo%20informe%202%20Mortalidad%20y%20salud%20en%20fronteras.pdf</url>
    <description>Second Report of the National Health Observatory: Mortality 1998-2011 and health situation in land border municipalities in Colombia</description>
  </link>
  <reference>
    <citation>Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323-33. doi: 10.1016/S2214-109X(14)70227-X. Epub 2014 May 5. Review.</citation>
    <PMID>25103301</PMID>
  </reference>
  <reference>
    <citation>Surgers L, Valin N, Carbonne B, Bingen E, Lalande V, Pacanowski J, Meyohas MC, Girard PM, Meynard JL. Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum. Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-13. doi: 10.1007/s10096-012-1724-5. Epub 2012 Aug 21.</citation>
    <PMID>22907333</PMID>
  </reference>
  <reference>
    <citation>Acosta CD, Bhattacharya S, Tuffnell D, Kurinczuk JJ, Knight M. Maternal sepsis: a Scottish population-based case-control study. BJOG. 2012 Mar;119(4):474-83. doi: 10.1111/j.1471-0528.2011.03239.x. Epub 2012 Jan 18.</citation>
    <PMID>22251396</PMID>
  </reference>
  <reference>
    <citation>Kankuri E, Kurki T, Carlson P, Hiilesmaa V. Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand. 2003 Aug;82(8):730-5.</citation>
    <PMID>12848644</PMID>
  </reference>
  <reference>
    <citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644-55. Review.</citation>
    <PMID>1303622</PMID>
  </reference>
  <reference>
    <citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.</citation>
    <PMID>26903338</PMID>
  </reference>
  <reference>
    <citation>Jain S, Guleria K, Suneja A, Vaid NB, Ahuja S. Use of the Sequential Organ Failure Assessment score for evaluating outcome among obstetric patients admitted to the intensive care unit. Int J Gynaecol Obstet. 2016 Mar;132(3):332-6. doi: 10.1016/j.ijgo.2015.08.005. Epub 2015 Dec 2.</citation>
    <PMID>26792141</PMID>
  </reference>
  <reference>
    <citation>Arts DG, de Keizer NF, Vroom MB, de Jonge E. Reliability and accuracy of Sequential Organ Failure Assessment (SOFA) scoring. Crit Care Med. 2005 Sep;33(9):1988-93.</citation>
    <PMID>16148470</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 8, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>qSOFA</keyword>
  <keyword>Systemic Inflammatory Response Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

